United States· US:54828-001_54797009-949b-cdd1-e063-6294a90afaf4
Neuraceq
A medicinal product containing florbetaben f-18, registered in United States by Lantheus Biosciences Ltd., a Lantheus Company.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- FLORBETABEN F-18
- Manufacturer
- Lantheus Biosciences Ltd., a Lantheus Company
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 26, 2026
Packs & prices · 1
- ndc1154828-001-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Florbetaben f-18 in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaNEURACEQISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
- CzechiaNEURACEQLantheus Germany GmbH, Berlín
- SpainNEURACEQ 300 MBq/ml solucion inyectableLantheus Germany Gmbh
- BelgiumNeuraceq 300 MBq/mlLantheus Germany
- United KingdomNeuraceq [F-18] 300MBq solution for injection vialsLantheus Biosciences Ltd
- NetherlandsNeuraceq 300 MBq/mL, oplossing voor injectieLife Molecular Imaging GmbH
- SwedenNeuraceq 300 MBq/ml Injektionsvätska, lösningLantheus Germany GmbH
- FinlandNeuraceqLantheus Germany GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Neuraceq
- Liechtenstein · Neuraceq
- Norway · Neuraceq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2a51d9f-52a1-4849-9aed-f6cb63bf7e31 GET /v1/drugs/a2a51d9f-52a1-4849-9aed-f6cb63bf7e31?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "135",
"substance": "FLORBETABEN F-18",
"productndc": "54828-001",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mCi/mL",
"application_number": "NDA204677",
"marketing_category": "NDA"
}See everything about florbetaben f-18.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.